The COVID-19 pandemic has brought a new global awareness of the accessibility of diagnostics: we need to test to protect with equal access for all. In this episode of Global Health Matters, we answer key questions such as “how available are essential diagnostics in low- and middle-income countries (LMICs)?”
Host Garry Aslanyan interviews our special guests who have a deep understanding of diagnostics and their application worldwide. Bill Rodriguez is CEO of FIND, the global alliance for diagnostics, and is also founder of his own diagnostics company, Daktari Diagnostics. Our second guest is Sikhulile Moyo who led the team that helped discover the Omicron variant in Botswana through careful cross-examination of COVID-19 tests.
Join us in this podcast episode to understand the state of diagnostic testing in LMICs and how to achieve equity in access to testing in all countries.
· Bill Rodriguez, CEO, FIND
· Sikhulile Moyo, Research Laboratory Director, Botswana Harvard AIDS Institute Partnership
Related documents, transcripts and other information can be found on our website at
We are keen to engage with you, our listeners, at every step of the way – please feel free to suggest topics and questions to be discussed and share your feedback by dropping us a line at TDRpod@who.int.
Subscribe to Global Health Matters podcast newsletter.
Follow @TDRnews on Twitter, TDR on LinkedIn and @ghm_podcast on Instagram for updates.
Disclaimer: The views, information, or opinions expressed during the Global Health Matters podcast series are solely those of the individuals involved and do not necessarily represent those of TDR or the World Health Organization.